RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Addressing Key Challenges in Drug Safety (Strategic Focus)
Mar 2008 - 34 pages - $3,395
Biosimilars Update
Apr 2011 - $695
Pharmacovigilance and Related Developments 2011-2021
Aug 2011 - 117 pages - $2,350
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
May 2011 - 88 pages - $3,500
Drug Combinations: New Rules, New Opportunities
May 2011 - $895
Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals
Apr 2009 - 136 pages - $2,350
Risk Evaluation and Mitigation Strategies (REMS)
Aug 2011 - 120 pages - $3,835
IT Services Market in the US to 2014
Jul 2010 - 70 pages - $495
IT Services Market in the UK to 2014
Jul 2010 - 70 pages - $495
IT Services Market in New Zealand to 2014
Jul 2010 - 70 pages - $495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us